Table 2.
Experiment | SH-SY5Y-MOCK | SH-SY5Y-APP695 | SH-SY5Y-MOCK | SH-SY5Y-APP695 | |||||
---|---|---|---|---|---|---|---|---|---|
HstP 10 µM |
Control | HstP 10 µM |
Control | HstN 10 µM |
Control | HstN 10 µM |
Control | ||
Oxygraph
O2 consumption (pmol/(s-UI)) |
Endogenous | 318 ± 45 | 311 ± 77 | 301 ± 47 | 322 ± 42 | 180 ± 26 | 187 ± 40 | 254 ± 62 | 273 ± 45 |
Permeabilized | 18 ± 11 | 23 ± 20 | 32 ± 14 | 37 ± 12 | 40 ± 15 * | 24 ± 13 | 65 ± 30 | 69 ± 30 | |
Leak I (G+M) | 102 ± 32 | 116 ± 22 | 155 ± 25 | 174 ± 32 | 151 ± 27 | 153 ± 51 | 179 ± 48 | 159 ± 51 | |
Complex I | 686 ± 96 | 643 ± 140 | 546 ± 140 | 547 ± 155 | 452 ± 45 * | 389 ± 53 | 454 ± 73 ** | 370 ± 74 | |
OXPHOS | 1185 ± 163 | 1091 ± 358 | 758 ± 286 | 865 ± 346 | 669 ± 57 | 619 ± 94 | 710 ± 140 * | 588 ± 149 | |
ETC | 1395 ± 219 | 1275 ± 449 | 874 ± 274 | 1064 ± 240 | 854 ± 148 | 787 ± 181 | 753 ± 134 * | 672 ± 182 | |
Complex II | 958 ± 112 | 883 ± 138 | 600 ± 220 | 739 ± 179 | 549 ± 100 | 468 ± 94 | 522 ± 110 **** | 324 ± 107 | |
Leak II (Omy) | 910 ± 171 | 850 ± 297 | 608 ± 242 | 608 ± 261 | 477 ± 101 | 410 ± 93 | 311 ± 110 * | 219 ± 78 | |
Complex IV | 1519 ± 190 | 1446 ± 232 | 411 ± 248 | 415 ± 223 | 898 ± 258 | 824 ± 173 | 761 ± 172 * | 619 ± 186 | |
Citrate synthase activity (IU/106 cells) | 0.01378 ± 0.02 |
0.0138787 ± 0.004 |
0.01699 ± 0.001 |
0.0191789 ± 0.002 |
0.0231924 ± 0.005 |
0.0223699 ± 0.004 |
0.018955 ± 0.003 |
0.0178201 ± 0.003 |
|
ATP levels (% of control) | 0.01 µM | 105 ± 11 | 104 ± 3 | 114 ± 5 *** | 100 ± 5 | ||||
0.1 µM | 108 ± 6 | 108 ± 3 | 114 ± 7 ** | 106 ± 3 * | |||||
1 µM | 109 ± 7 * | 109 ± 2 * | 113 ± 6 ** | 107 ± 6 ** | |||||
10 µM | 100 ± 10 | 107 ± 6 | 118 ± 3 **** | 113 ± 4 *** |